Daniel J Drucker
@danieljdrucker
A clinician scientist at LTRI @sinaihealth studying GLP-1, diabetes, obesity and the gut endocrine system Proud 🇨🇦Not going anywhere Am 🇮🇱Chai
ID: 292334056
http://glucagon.com 03-05-2011 13:51:01
30,30K Tweet
30,30K Followers
1,1K Following
A review of 3 trials in persons with type 2 diabetes, demonstrated consistent cardiovascular and kidney benefits of GLP-1 receptor agonists regardless of SGLT2 inhibitor use Circulation ahajournals.org/doi/10.1161/CI… #T2D #heartdisease #heartfailure #CKD